SAN JOSE, Calif. (Reuters) -Theranos founder Elizabeth Holmes took the stand on Friday to defend herself against charges of defrauding investors and patients about the now-defunct blood-testing startup once valued at $9 billion.
Holmes, 37, is accused of making false claims about Theranos, including that its technology could run a range of diagnostic tests more quickly and accurately than conventional laboratory testing with a drop of blood from a finger prick.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
